Aequus Pharmaceuticals Inc. (AQSZF)
OTCMKTS
· Delayed Price · Currency is USD
0.0040
0.00 (0.00%)
At close: May 2, 2025
Aequus Pharmaceuticals Statistics
Total Valuation
AQSZF has a market cap or net worth of 478,541. The enterprise value is 5.21 million.
Market Cap | 478,541 |
Enterprise Value | 5.21M |
Important Dates
The last earnings date was Thursday, May 1, 2025.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 132.63M |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 113.16M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.18 |
PB Ratio | -0.11 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.44 |
EV / Sales | 12.37 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
Current Ratio | 0.04 |
Quick Ratio | 0.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -157.74% |
Return on Invested Capital (ROIC) | -320.86% |
Return on Capital Employed (ROCE) | 39.70% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.62 |
Inventory Turnover | 3.12 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.45% in the last 52 weeks. The beta is -0.35, so AQSZF's price volatility has been lower than the market average.
Beta (5Y) | -0.35 |
52-Week Price Change | -57.45% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.03 |
Relative Strength Index (RSI) | 44.58 |
Average Volume (20 Days) | 45,398 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AQSZF had revenue of 406,047 and -1.51 million in losses. Loss per share was -0.01.
Revenue | 406,047 |
Gross Profit | 230,952 |
Operating Income | -1.65M |
Pretax Income | -1.51M |
Net Income | -1.51M |
EBITDA | -1.65M |
EBIT | -1.65M |
Loss Per Share | -0.01 |
Balance Sheet
The company has 34,919 in cash and 4.60 million in debt, giving a net cash position of -4.56 million.
Cash & Cash Equivalents | 34,919 |
Total Debt | 4.60M |
Net Cash | -4.56M |
Net Cash Per Share | n/a |
Equity (Book Value) | -4.49M |
Book Value Per Share | -0.03 |
Working Capital | -4.53M |
Cash Flow
Operating Cash Flow | -1.15M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 56.88% |
Operating Margin | -407.47% |
Pretax Margin | -372.74% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AQSZF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -316.27% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |